These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 3342412

  • 61. Plasma and leukemic cell pharmacokinetics of high-dose N4-behenoyl-1-beta-D-arabinofuranosylcytosine in acute leukemia patients.
    Yoshida T, Kobayashi K, Okabe Y, Okumura H, Matano S, Kanno M, Takeda Y, Ohtake S, Nakamura S, Matuda T.
    J Clin Pharmacol; 1994 Jan; 34(1):52-9. PubMed ID: 8132852
    [Abstract] [Full Text] [Related]

  • 62. Phenotypic analysis of 1-B-D-arabinofuranosylcytosine deamination in patients treated with high doses and correlation with response.
    Kreis W, Lesser M, Budman DR, Arlin Z, DeAngelis L, Baskind P, Feldman EJ, Akerman S.
    Cancer Chemother Pharmacol; 1992 Jan; 30(2):126-30. PubMed ID: 1600592
    [Abstract] [Full Text] [Related]

  • 63. Clinical results and pharmacokinetics of high-dose cytosine arabinoside (HD ARA-C).
    Breithaupt H, Pralle H, Eckhardt T, von Hattingberg M, Schick J, Löffler H.
    Cancer; 1982 Oct 01; 50(7):1248-57. PubMed ID: 7104969
    [Abstract] [Full Text] [Related]

  • 64. Alteration of the pharmacokinetics of high-dose ara-C by its metabolite, high ara-U in patients with acute leukemia.
    Capizzi RL, Yang JL, Cheng E, Bjornsson T, Sahasrabudhe D, Tan RS, Cheng YC.
    J Clin Oncol; 1983 Dec 01; 1(12):763-71. PubMed ID: 6668493
    [Abstract] [Full Text] [Related]

  • 65. Simultaneous determination of 1-β-d-Arabinofuranosylcytosine and two metabolites, 1-β-d-Arabinofuranosyluracil and 1-β-d-Arabinofuranosylcytosine triphosphate in leukemic cell by HPLC-MS/MS and the application to cell pharmacokinetics.
    Liang D, Wang W, Jiang X, Yin S.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jul 01; 962():14-19. PubMed ID: 24880220
    [Abstract] [Full Text] [Related]

  • 66. Physiologic disposition of cytosine arabinoside and its derivatives in man.
    Kreis W, Woodcock TM, Meyers MB, Carlevarini LA, Krakoff IH.
    Cancer Treat Rep; 1977 Jul 01; 61(4):723-6. PubMed ID: 195729
    [Abstract] [Full Text] [Related]

  • 67. [Pharmacokinetics of N4-behenoyl-1-beta-D-arabinofuranosylcytosine after intraperitoneal administration].
    Noda T, Oku M, Kiyozuka Y, Maruyama M, Adachi S, Akada S, Okamura Y, Ichijo M.
    Gan To Kagaku Ryoho; 1988 Oct 01; 15(10):2929-35. PubMed ID: 3178241
    [Abstract] [Full Text] [Related]

  • 68. A sensitive and specific radioimmunoassay for 1-beta-D-arabino-furanosylcytosine.
    Shimada N, Ueda T, Yokoshima T, Oh-Ishi J, Oh-oka T.
    Cancer Lett; 1984 Sep 01; 24(2):173-8. PubMed ID: 6478445
    [Abstract] [Full Text] [Related]

  • 69. Clinical use of intermediate to high dose of N4-behenoyl-1-beta-D-arabinofuranosylcytosine in children with acute leukemia.
    Takashima Y.
    J Clin Pharmacol; 1988 Apr 01; 28(4):356-62. PubMed ID: 3164731
    [Abstract] [Full Text] [Related]

  • 70. NONMEM population pharmacokinetic studies of cytosine arabinoside after high-dose and after loading bolus followed by continuous infusion of the drug in pediatric patients with leukemias.
    Periclou AP, Avramis VI.
    Cancer Chemother Pharmacol; 1996 Apr 01; 39(1-2):42-50. PubMed ID: 8995498
    [Abstract] [Full Text] [Related]

  • 71. Pharmacokinetics of ara-C and ara-U in plasma and CSF after high-dose administration of cytosine arabinoside.
    DeAngelis LM, Kreis W, Chan K, Dantis E, Akerman S.
    Cancer Chemother Pharmacol; 1992 Apr 01; 29(3):173-7. PubMed ID: 1733548
    [Abstract] [Full Text] [Related]

  • 72. Tetrahydrouridine specifically facilitates deoxycytidine incorporation into herpes simplex virus DNA.
    North TW, Mathews CK.
    J Virol; 1981 Mar 01; 37(3):987-93. PubMed ID: 6262539
    [Abstract] [Full Text] [Related]

  • 73. Resistance to 1-Beta-d-arabinofuranosylcytosine and hypersensitivity to bleomycin in ataxia-telangiectasia B-lymphoblastoid cell-lines.
    Li M, Shiraishi Y.
    Int J Oncol; 1994 Jun 01; 4(6):1173-81. PubMed ID: 21567034
    [Abstract] [Full Text] [Related]

  • 74. Determination of 1-beta-D-arabinofuranosylcytosine and 1-beta-D-arabinofuranosyluracil in human plasma by high-performance liquid chromatography.
    Linssen P, Drenthe-Schonk A, Wessels H, Haanen C.
    J Chromatogr; 1981 May 08; 223(2):371-8. PubMed ID: 7251792
    [Abstract] [Full Text] [Related]

  • 75. Epimer interconversion, isomerization, and hydrolysis of tetrahydrouridine: implications for cytidine deaminase inhibition.
    Xiang TX, Niemi R, Bummer P, Anderson BD.
    J Pharm Sci; 2003 Oct 08; 92(10):2027-39. PubMed ID: 14502542
    [Abstract] [Full Text] [Related]

  • 76. Plasma pharmacokinetics and oral bioavailability of 3,4,5,6-tetrahydrouridine, a cytidine deaminase inhibitor, in mice.
    Beumer JH, Eiseman JL, Parise RA, Florian JA, Joseph E, D'Argenio DZ, Parker RS, Kay B, Covey JM, Egorin MJ.
    Cancer Chemother Pharmacol; 2008 Aug 08; 62(3):457-64. PubMed ID: 18008070
    [Abstract] [Full Text] [Related]

  • 77. Induction of resistance to 1-beta-D-arabinofuranosylcytosine in human H9 cell line by simian immunodeficiency virus.
    Yusa K, Oh-hara T, Tsuruo T.
    Biochem Biophys Res Commun; 1995 Jan 17; 206(2):486-91. PubMed ID: 7826366
    [Abstract] [Full Text] [Related]

  • 78. 9-beta-D-arabinofuranosyladenine 5'-phosphate metabolism and excretion in humans.
    LePage GA, Naik SR, Katakkar SB, Khaliq A.
    Cancer Res; 1975 Nov 17; 35(11 Pt 1):3036-40. PubMed ID: 1182697
    [Abstract] [Full Text] [Related]

  • 79. Cytosine arabinoside deamination in human leukaemic myeloblasts and resistance to cytosine arabinoside therapy.
    Harris AL, Grahame-Smith DG, Potter CG, Bunch C.
    Clin Sci (Lond); 1981 Feb 17; 60(2):191-8. PubMed ID: 6940687
    [Abstract] [Full Text] [Related]

  • 80. Does the metabolite uracil arabinoside inhibit cytosine arabinoside (Ara-C) penetration into the cerebrospinal fluid during high-dose Ara-C therapy?
    van Prooijen HC, Muus P, Roelofs JM, Punt K.
    Scand J Haematol; 1986 Jan 17; 36(1):123-6. PubMed ID: 3456631
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.